Welcome to InvestSMART

You are currently viewing our site as a guest, which gives you limited access to our site features. By signing up for a free membership, you will receive our Investment Opportunity newsletters and have access to additional features for finding and comparing managed funds and shares. Registration is fast and simple, so please:

General Information

Imugene Limited
IMU
http://www.imugene.com
Biotechnology
15
1,330

Current Price Data+

Current Price Open High Low Last Close Volume Price Movement
$0.01 $0.01 $0.01 $0.01 $0.01 2511038 - ( No change )
  • +Security prices are delayed by least 20 minutes and are indicative only.

Company Overview

Business Description
Imugene Limited (IMU) is an Australian pharmaceutical company with a drug delivery platform at the centre of its assets known as Linguet. IMU currently focuses on consumer healthcare products and Vitamin D therapeutics.
Strategy Analysis
--

Financial Summary

Year to Jun NPAT EPS EPS chg (%) PER DPS Yield (%) Franking (%)
2014 A -2.1 -0.3 0.0% 0.0 0.0 0.0% 0.0%
2013 A -1.6 -0.5 0.0% 0.0 0.0 0.0% 0.0%
2012 A -1.0 -0.7 0.0% 0.0 0.0 0.0% 0.0%

Peer Comparison

Company Mkt Cap EPS Growth (%) P/E (%) Dividend Yield (%)
2012 A 2013 F 2014 F 2012 A 2013 F 2014 F 2012 A 2013 F 2014 F
CSL (CSL) $46,000M 0.0899 0.3345 0.0818 34.6414 25.9581 23.9950 1.21% 1.61% 1.83%
Imugene (IMU) $15M 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.00% 0.00% 0.00%
Mesoblast (MSB) $1,328M 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.00% 0.00% 0.00%
Monash IVF Group (MVF) $325M 0.0000 1.7120 0.3828 37.5000 13.8277 10.0000 0.00% 4.70% 6.50%
Sirtex Medical (SRX) $1,761M 0.2906 0.6077 0.6098 74.6731 46.4458 28.8521 0.45% 0.63% 1.03%

Financial Summary

Earnings P/E Ratio P/B Ratio P/E Growth
Company 0.00 0.00 1.55 0.00
Market 0.96 13.90 1.05 0.48
Sector 0.81 13.20 3.05 1.00

Directors

Name Position Start Date
Mr Charles Walker Chief Executive Officer, Managing Director 30/01/2015
Mr Paul Hopper Executive Chairman 31/10/2012
Mr Otto Buttula Non-Executive Director 07/07/2014
Dr Axel Hoos Non-Executive Director 20/12/2013

Management

Name Position
Phillip Hains Chief Financial Officer,Joint Company Secretary
Justyn Stedwell Company Secretary

Substantial Shareholders

Holding Name
68,296,875 (7.22%) Paul Hopper
62,000,000 (6.55%) WebInvest Pty Ltd
59,975,000 (6.34%) JK Nominees Pty Ltd
60,000,000 (6.34%) Oaktone Nominees Pty Limited <Grist Investment A/C>
60,000,000 (6.34%) Tisia Nominees Pty Ltd <Henderson Family A/C>

Calendar of Events

Date Event
26 February 2016 Report (Interim)
23 October 2015 Report (Annual)
27 August 2015 Report (Annual)
27 August 2015 Report (Prelim)
© 2011 Morningstar, Inc. All rights reserved. The data and content contained herein are not guaranteed to be accurate, complete or timely. Neither Morningstar, nor its affiliates nor their content providers will have any liability for use or distribution of any of this information. To the extent that any of the content above constitutes advice, it is general advice that has been prepared by Morningstar Australasia Pty Ltd ABN: 95 090 665 544, AFSL: 240892 (a subsidiary of Morningstar, Inc.), without reference to your objectives, financial situation or needs. Before acting on any advice, you should consider the appropriateness of the advice and we recommend you obtain financial, legal and taxation advice before making any financial investment decision. If applicable investors should obtain the relevant product disclosure statement and consider it before making any decision to invest. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). DISCLOSURE: Employees may have an interest in the securities discussed in this report. Please refer to our Financial Services Guide (FSG) for more information at www.morningstar.com.au/fsg.asp.